Inventor · disambiguated record
Jose Halperin
Also filed as: HALPERIN JOSE · HALPERIN JOSE A · HALPERIN JOSE ALBERTO · HALPERIN JOSÉ A
46 granted patents·18 pending applications·739 citations·filing 1993–2021
98Inventor score
Files withHARVARD COLLEGE28BEST DOCTORS INC7HALPERIN JOSE A6CHILDRENS MEDICAL CENTER4CHOREV MICHAEL2
Top patents by PatentIndex Score
64 records- 0194US8298779B2Methods, products and treatments for diabetesHALPERIN JOSE A·Filed 2011·Granted Oct 30, 2012·10 cites·27 claims
- 0294US6256613B1Medical consultation management systemHEALTH RESOURCES AND TECHNOLOG·Filed 1997·Granted Jul 3, 2001·155 cites·15 claims
- 0393US7767791B2Methods, products and treatments for diabetesHARVARD COLLEGE·Filed 2006·Granted Aug 3, 2010·14 cites·13 claims
- 0491US7737172B23-3-di-substituted-oxindoles as inhibitors of translation initiationHARVARD COLLEGE·Filed 2006·Granted Jun 15, 2010·19 cites·30 claims
- 0591US6835545B2Methods, products and treatments for diabetesHARVARD COLLEGE·Filed 2001·Granted Dec 28, 2004·30 cites·33 claims
- 0690US8404451B2Mass spectrometric methods and productsHALPERIN JOSE A·Filed 2011·Granted Mar 26, 2013·7 cites·29 claims
- 0790US7756721B1Health care management systemBEST DOCTORS INC·Filed 2000·Granted Jul 13, 2010·152 cites·20 claims
- 0889US8008024B2Methods, products and treatments for diabetesHARVARD COLLEGE·Filed 2008·Granted Aug 30, 2011·8 cites·2 claims
- 0989US7833725B2Mass spectrometric methods and productsHARVARD COLLEGE·Filed 2006·Granted Nov 16, 2010·7 cites·18 claims
- 1089US5512591ATreatments for diseases characterized by neovascularizationHARVARD COLLEGE·Filed 1993·Granted Apr 30, 1996·57 cites·24 claims
- 1188US7049082B2Methods, products and treatments for diabetesHARVARD COLLEGE·Filed 2004·Granted May 23, 2006·21 cites·20 claims
- 1287US11161910B2Glycated CD59 peptides, their preparation, and uses thereofHARVARD COLLEGE·Filed 2018·Granted Nov 2, 2021·2 cites·10 claims
- 1385US9421211B2N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiationAKTAS BERTAL HUSEYIN·Filed 2010·Granted Aug 23, 2016·7 cites·2 claims
- 1485US9068006B2Glycated CD59 peptides, their preparation, and uses thereofHALPERIN JOSE A·Filed 2011·Granted Jun 30, 2015·6 cites·3 claims
- 1585US6028103ATriaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferationCHILDRENS MEDICAL CENTER·Filed 1997·Granted Feb 22, 2000·36 cites·42 claims
- 1683US9417248B2Surrogates of post-translationally modified proteins and uses thereofCHOREV MICHAEL·Filed 2012·Granted Aug 16, 2016·4 cites·15 claims
- 1781US8268879B23-3-di-substituted-oxindoles as inhibitors of translation initiationHALPERIN JOSE A·Filed 2010·Granted Sep 18, 2012·4 cites·5 claims
- 1881US7439330B2Anti-glycated CD59 antibodies and uses thereofHARVARD COLLEGE·Filed 2004·Granted Oct 21, 2008·17 cites·15 claims
- 1980US11891448B2Glycated CD59 peptides, their preparation, and uses thereofHARVARD COLLEGE·Filed 2021·Granted Feb 6, 2024·0 cites·8 claims
- 2080US5358959AMethods for treating arteriosclerosisHARVARD COLLEGE·Filed 1993·Granted Oct 25, 1994·39 cites·21 claims
- 2179US8093009B2Mass spectrometric methods and productsHALPERIN JOSE·Filed 2010·Granted Jan 10, 2012·3 cites·11 claims
- 2277US8999646B2Quality control bioassays for nutriceutical and medicinal productsHALPERIN JOSE A·Filed 2010·Granted Apr 7, 2015·1 cites·13 claims
- 2377US7761308B2Medical consultation management systemBEST DOCTORS INC·Filed 2000·Granted Jul 20, 2010·20 cites·4 claims
- 2476US8257931B2Regulation of protein synthesisWAGNER GERHARD·Filed 2006·Granted Sep 4, 2012·5 cites·40 claims
- 2575US8088816B23-3-di-substituted-oxindoles as inhibitors of translation initiationHALPERIN JOSE A·Filed 2010·Granted Jan 3, 2012·2 cites·13 claims
- 2675US7846962B23-3-di-substituted-oxindoles as inhibitors of translation initiationHARVARD COLLEGE·Filed 2009·Granted Dec 7, 2010·1 cites·7 claims
- 2775US6331564B1Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory diseaseION PHARMACEUTICALS INC·Filed 1998·Granted Dec 18, 2001·43 cites·13 claims
- 2871US8354440B23-3-di-substituted-oxindoles as inhibitors of translation initiationHARVARD COLLEGE·Filed 2011·Granted Jan 15, 2013·1 cites·4 claims
- 2971US8044089B23-3-di-substituted-oxindoles as inhibitors of translation initiationHARVARD COLLEGE·Filed 2010·Granted Oct 25, 2011·1 cites·13 claims
- 3070US5633274ACancer treatmentsHARVARD COLLEGE·Filed 1993·Granted May 27, 1997·34 cites·26 claims
- 3164US6800658B2Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferationCHILDRENS MEDICAL CENTER·Filed 2002·Granted Oct 5, 2004·3 cites·16 claims
- 3262US2013189711A1Methods, products and treatments for diabetesHARVARD COLLEGE·Filed 2012·Application pending·0 cites
- 3358US2013204643A1Health Care Management SystemBEST DOCTORS INC·Filed 2013·Application pending·0 cites
- 3457US10732186B2Methods and reagents for the assessment of gestational diabetesHARVARD COLLEGE·Filed 2014·Granted Aug 4, 2020·0 cites·4 claims
- 3556US10309973B2Surrogates of post-translationally modified proteins and uses thereofHARVARD COLLEGE·Filed 2016·Granted Jun 4, 2019·0 cites·8 claims
- 3655US2010287000A1Medical consultation management systemBEST DOCTORS INC·Filed 2010·Application pending·0 cites
- 3754US9932300B2N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiationHARVARD COLLEGE·Filed 2016·Granted Apr 3, 2018·0 cites·1 claims
- 3854US2018293679A1Systems and methods of a platform for candidate identificationColleMark LLC·Filed 2018·Application pending·0 cites
- 3954US2008275732A1Using patterns of medical treatment codes to determine when further medical expertise is called forBEST DOCTORS INC·Filed 2007·Application pending·0 cites
- 4053US2015199488A1Systems and Methods for Interpreting Medical InformationBEST DOCTORS INC·Filed 2014·Application pending·0 cites
- 4152US8969573B2Compounds for the inhibition of cellular proliferationCHOREV MICHAEL·Filed 2011·Granted Mar 3, 2015·0 cites·1 claims
- 4252US5643936ATreatments for diseases characterized by neovascularizationHARVARD COLLEGE·Filed 1995·Granted Jul 1, 1997·7 cites·8 claims
- 4352US2015315286A1Glycated cd59 peptides, their preparation, and uses thereofHARVARD COLLEGE·Filed 2015·Application pending·0 cites
- 4452US2002119953A1Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory diseaseFiled 2001·Application pending·0 cites
- 4551US2011010190A1Health care management systemBEST DOCTORS INC·Filed 2010·Application pending·0 cites
- 4651US2016106711A13-3-Di-Substituted-Oxindoles as Inhibitors of Translation InitiationHARVARD COLLEGE·Filed 2013·Application pending·0 cites
- 4750US9952200B2Cell based quality control bioassays for nutriceutical and medicinal productsHARVARD COLLEGE·Filed 2013·Granted Apr 24, 2018·0 cites·19 claims
- 4850US7342038B2Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferationHARVARD COLLEGE·Filed 2004·Granted Mar 11, 2008·0 cites·15 claims
- 4949US6066319ADrug delivery using terminal complement componentsHARVARD COLLEGE·Filed 1996·Granted May 23, 2000·11 cites·8 claims
- 5049US2022251605A1Membrane attack complexes and uses thereofBRIGHAM & WOMENS HOSPITAL INC·Filed 2020·Application pending·0 cites
Showing the top 50 of 64 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Jose Halperin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →